Alissa Rumin: Starting a New Chapter in Hemophilia and Thrombosis Research
Alissa Rumin, Clinical Research Coordinator at University of Colorado Anschutz, shared a post on LinkedIn:
“I am thrilled to share that I have accepted a Clinical Research Coordinator position at the University of Colorado Anschutz Hemophilia and Thrombosis Center!
This opportunity is especially meaningful as it represents a full-circle moment in my journey.
I wrote my college admission essay about my interest in gene therapy and its potential to improve the lives of those living with bleeding and clotting disorders.
The HTC has supported my family for years, and I am incredibly grateful for the opportunity to give back to this wonderful community.
I owe a huge thank you to my University of Denver professors, advisors, and Principal Investigators, especially Ann Wehman, for the unwavering support, mentorship, and inspiration along the way.
I am beyond excited for this new chapter and look forward to helping patients access the resources they deserve.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 08:43Joy Duemke: Optimizing Stem Cell Collection for Gene Therapy Success
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026